Chiara Pizzamiglio
@chiarapizzamig
Neurologist, Mitochondrial diseases, biomarkers and outcome measures, @UCLIoN @LondonMito
ID: 1499075003421179911
02-03-2022 17:32:29
116 Tweet
160 Takipçi
146 Takip Edilen
Thank you to our really great and dedicated UCL UCLH Centre for Neuromuscular Diseases team for today completing our 15th annual 10K run raising funds to advance our patient care and research UCLH UCL Brain Sciences UCL Queen Square Institute of Neurology #JustGiving justgiving.com/team/cnmd10k?u…
Yesterday the team broke a sweat running the ASICS London 10K for the National The National Brain Appeal, who support cruicial projects in neurological disease 🏃♀️ UCL_QS_CNMD UCL Queen Square Institute of Neurology UCL #TeamBrainAppeal #London10K Prof Michael Hanna Robert Pitceathly Will Macken Chiara Pizzamiglio
Excited to share our last study exploring how MRgFUS impacts the vestibular system, potentially paving the way for new therapies In Parkinson’s disease and TBI. Proud to contribute to this important work! Imperial Department of Brain Sciences Barry Seemungal 🇬🇧 🇹🇹 Vestibular Neurology Research Group
Thrilled to share our new findings on vestibular prepulse inhibition of the blink reflex. A promising neurophysiological marker for brainstem-level vestibulo-motor integration! Sarah Hösli Zaeem Hadi Dr Mo Sahib Mahmud Barry Seemungal 🇬🇧 🇹🇹 Imperial Department of Brain Sciences IFCN and its Clinical Neurophysiology journals
The UCL portico has been green for mito all this week to raise awareness for this under-diagnosed group of diseases #worldmitoweek2024 #lightupformito The Lily Foundation
An early clinical trial, led by researchers at UCL Queen Square Institute of Neurology, shows promising results for adults with primary mitochondrial disease, with reduced fatigue and improved functional strength. Chiara Pizzamiglio Robert Pitceathly bit.ly/4ge2Igd
A novel molecule, KL1333 has shown promising results for adults with primary mitochondrial disease in an early stage clinical trial, led by researchers at UCL Queen Square Institute of Neurology, with reduced fatigue & improved functional strength. Chiara Pizzamiglio Robert Pitceathly bit.ly/4ge2Igd